等待开盘 10-23 09:30:00 美东时间
+0.860
+4.06%
今日重点评级关注:HC Wainwright & Co.:维持Annexon"买入"评级,目标价从14美元升至25美元;HC Wainwright & Co.:维持Alto Neuroscience"买入"评级,目标价从55美元升至60美元
10-20 12:36
Wells Fargo analyst James Feldman maintains Four Corners Property Tr (NYSE:FCPT) with a Equal-Weight and lowers the price target from $26 to $22.
10-20 01:24
今日重点评级关注:Jones Trading:维持Opus Genetics"买入"评级,目标价从10美元升至17美元;Citizens:维持Rezolute"跑赢大市"评级,目标价从11美元升至15美元
10-07 17:30
JP Morgan analyst Anthony Paolone maintains Four Corners Property Tr (NYSE:FCPT) with a Neutral and lowers the price target from $29 to $26.
10-06 23:15
今日重点评级关注:HC Wainwright & Co.:维持Gossamer Bio"买入"评级,目标价从2美元升至90美元;巴克莱:维持Ultragenyx Pharmaceutical"超配"评级,目标价从32美元升至35美元
09-22 16:25
Evercore ISI Group analyst Steve Sakwa maintains Four Corners Property Tr (NYSE:FCPT) with a In-Line and lowers the price target from $28 to $26.
09-22 00:21
Barclays analyst Richard Hightower maintains Four Corners Property Tr (NYSE:FCPT) with a Equal-Weight and raises the price target from $29 to $30.
09-04 20:32
今日重点评级关注:摩根大通:维持Ultragenyx Pharmaceutical"超配"评级,目标价从75美元升至80美元;瑞杰金融:维持英伟达"强力买入"评级,目标价从330美元升至352美元
08-26 08:37
Citizens analyst Mitch Germain reiterates Four Corners Property Tr (NYSE:FCPT) with a Market Outperform and maintains $28 price target.
08-25 21:16
今日重点评级关注:HC Wainwright & Co.:维持Enlivex"买入"评级,目标价从20美元升至80美元;Canaccord Genuity:维持Pharming Group NV Sponsored ADR"买入"评级,目标价从37美元升至38美元
08-04 11:45